Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for low responders after bariatric surgery
NL-OMON49525Withdrawn
- Sponsor
- Nederlandse Obesitas Kliniek
- Start
- Dec 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Trial of liraglutide, sponsored by Nederlandse Obesitas Kliniek. Planned start Dec 2020; status: withdrawn.
02
Drugs
Beyond the preview
Go deeper on NL-OMON49525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49525.